GANX

1.84

6.12% -0.12

Vorhandelsmarkt: 1.84

Gain Therapeutics Inc (GANX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt GANX? Forum Prognose

Schlusskurs vom Vortag:

$1.96

Offen:

$1.99

24-Stunden-Volumen:

887.65K

Relative Volume:

1.36

Marktkapitalisierung:

$66.15M

Einnahmen:

$210.70K

Nettoeinkommen (Verlust:

$-21.37M

KGV:

-1.6727

EPS:

-1.1

Netto-Cashflow:

$-21.10M

1W Leistung:

-5.64%

1M Leistung:

-4.17%

6M Leistung:

-10.68%

1J Leistung:

-20.69%

1-Tages-Spanne:

$1.79

$2.04

1-Wochen-Bereich:

$1.74

$2.08

52-Wochen-Spanne:

$1.41

$2.81

Gain Therapeutics Inc Stock (GANX) Company Profile

Firmenname

Gain Therapeutics Inc

Sektor

Healthcare (1136)

Branche

Biotechnology (633)

Telefon

(301) 500-1556

Adresse

4800 HAMPDEN LANE, BETHESDA

Mitarbeiter

Twitter

Nächster Verdiensttermin

2025-03-26

Neueste SEC-Einreichungen

GANX's Discussions on Twitter

Vergleichen Sie GANX mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
GANX Gain Therapeutics Inc	1.84	70.46M	210.70K	-21.37M	-21.10M	-1.10
VRTX Vertex Pharmaceuticals Inc	426.00	109.11B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	642.25	68.50B	14.25B	4.58B	3.88B	41.77
ALNY Alnylam Pharmaceuticals Inc	434.07	60.25B	3.21B	43.57M	221.36M	0.2405
ARGX Argen X Se Adr	826.28	50.39B	3.06B	1.28B	447.35M	19.67
INSM Insmed Inc	186.23	40.44B	447.02M	-1.18B	-868.57M	-6.1812

Gain Therapeutics Inc Stock (GANX) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-03-07	Eingeleitet	Scotiabank	Sector Outperform
2024-12-06	Eingeleitet	ROTH MKM	Buy
2024-08-14	Fortgesetzt	Oppenheimer	Outperform
2021-04-12	Eingeleitet	BTIG Research	Buy
2021-04-12	Eingeleitet	Oppenheimer	Outperform

Gain Therapeutics Inc Aktie (GANX) Neueste Nachrichten

03:57 AM

Why Gain Therapeutics Inc. stock remains on buy listsPortfolio Growth Summary & Smart Money Movement Tracker - newser.com

03:57 AM

03:48 AM

Gain Therapeutics Inc. stock outlook for YEARWeekly Gains Report & Verified Momentum Stock Alerts - newser.com

03:48 AM

01:37 AM

Building trade automation scripts for Gain Therapeutics Inc.Weekly Stock Report & Safe Swing Trade Setups - newser.com

01:37 AM

01:29 AM

Sentiment analysis tools applied to Gain Therapeutics Inc.Trend Reversal & Fast Exit/Entry Strategy Plans - newser.com

01:29 AM

Nov 03, 2025

Is Gain Therapeutics Inc. stock ready for a breakoutSell Signal & AI Enhanced Trade Execution Alerts - newser.com

Nov 03, 2025

Will Gain Therapeutics Inc. stock go up soonQuarterly Profit Review & Detailed Earnings Play Alerts - newser.com

Nov 03, 2025

Advanced analytics toolkit walkthrough for Gain Therapeutics Inc.2025 Pullback Review & Daily Stock Trend Reports - newser.com

Nov 03, 2025

Using R and stats models for Gain Therapeutics Inc. forecastingTrade Entry Report & Weekly Stock Breakout Alerts - newser.com

Nov 03, 2025

Gain Therapeutics Inc. stock trend outlook and recovery pathPortfolio Gains Summary & Daily Price Action Insights - newser.com

Nov 03, 2025

Is Gain Therapeutics Inc. stock undervalued vs historical averages2025 Big Picture & Real-Time Chart Breakout Alerts - newser.com

Nov 03, 2025

Is Gain Therapeutics Inc. stock entering bullish territoryTrade Volume Summary & Consistent Profit Alerts - newser.com

Nov 03, 2025

Is Gain Therapeutics Inc. stock a dividend growth opportunity2025 Fundamental Recap & Safe Investment Capital Preservation Plans - newser.com

Nov 03, 2025

Is Gain Therapeutics Inc. stock a buy before product launchesQuarterly Portfolio Review & AI Driven Price Predictions - newser.com

Nov 03, 2025

Nov 02, 2025

Using Python tools to backtest Gain Therapeutics Inc. strategies2025 Sector Review & Low Risk High Win Rate Picks - newser.com

Nov 02, 2025

How risky is Gain Therapeutics Inc. stock now2025 Support & Resistance & Weekly Chart Analysis and Trade Guides - newser.com

Nov 02, 2025

Can machine learning forecast Gain Therapeutics Inc. recoveryTrade Ideas & Long Hold Capital Preservation Tips - newser.com

Nov 02, 2025

Can Gain Therapeutics Inc. stock deliver sustainable ROETrade Volume Report & Weekly Setup with ROI Potential - newser.com

Nov 02, 2025

Nov 01, 2025

Will Gain Therapeutics Inc. stock deliver strong dividend growthJuly 2025 Levels & Smart Allocation Stock Tips - newser.com

Nov 01, 2025

Oct 31, 2025

Gain Therapeutics Advances Parkinson’s Treatment with GT-02287 Study - MSN

Oct 31, 2025

Oct 30, 2025

Gain Therapeutics, Inc. (NASDAQ:GANX) Short Interest Up 200.7% in October - MarketBeat

Oct 30, 2025